Hepatocellular Cancer Therapy
Research on hepatocellular cancer therapy published by scientists at Massachusetts General Hospital
Published in Medical Imaging Week, March 29th, 2008
Fresh data on hepatocellular cancer are presented in the report 'Early antiangiogenic activity of bevacizumab evaluated by computed tomography perfusion scan in patients with advanced hepatocellular carcinoma.' According to a study from the United States, "Hepatocellular carcinoma (HCC) is a highly vascularized tumor with a poor prognosis. In a phase II study that combined bevacizumab with gemcitabine and oxaliplatin in advanced HCC, we examined computed tomography perfusion (CTp) scan parameters as surrogate markers of angiogenesis after bevacizumab administration."
"HCC patients received bevacizumab alone i.v. at 10 mg/kg on day 1 during cycle 1. CTp scanning was...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Imaging Week
Source: Medical Imaging Week (2008-03-29)
More Articles from Medical Imaging Week
- Biopsy
Studies from Kurume University, Medical Department reveal new findings on biopsy - Breast Cancer
Findings from Seoul National University advance knowledge in breast cancer - Breast Cancer
National University reports research in breast cancer - Breast Cancer
Research from T.S. Field and co-researchers provides new data on breast cancer - Breast Cancer
Research reports on breast cancer from Meharry Medical College provide new insights - Breast Cancer
Studies in the area of breast cancer reported from L. Teran and co-researchers - More from this issue of Medical Imaging Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
